CEO RK's Performance

Quote
anonymous said:
You're all welcome. We strive to provide a work experience here that satisfies both your personal and professional development and growth. Please review the quarterly update if you have not already done so. We performed well this past quarter and if we failed to meet your expectations, please make the move now to exit before you continue to taint the rest of our groups optimism and excitement over the future success of this great entity.
Click to expand...


I noticed you did not dispute any of my factual information, so I assume you are in concurrence with the facts. I take it that you just dispute the conclusion.

We have a five times bigger sales organization and yet we sold $700,000 less Vision Sci products than sold by that earlier smaller sales organization, and strangely you call that good performance!!!

At best you are a bit weird, at worst you are an ignorant fool…….where do you fall on this continuum?

What am I missing? Ah, I forgot, I am supposed to be living in La-La land, as the previous commentator reminds us, where that kind of performance would that be considered good.
 






anonymous said:
I noticed you did not dispute any of my factual information, so I assume you are in concurrence with the facts. I take it that you just dispute the conclusion.

We have a five times bigger sales organization and yet we sold $700,000 less Vision Sci products than sold by that earlier smaller sales organization, and strangely you call that good performance!!!

At best you are a bit weird, at worst you are an ignorant fool…….where do you fall on this continuum?

What am I missing? Ah, I forgot, I am supposed to be living in La-La land, as the previous commentator reminds us, where that kind of performance would that be considered good.
Click to expand...

this sorry ass is neither weird nor ignorant. cant you see that she is paid to be the mouth piece of the company to defend the un-defendable, an impossible task. so go easy on her, will'ya!!
 






Heavens, Rob how long can you justify remaining our CEO.

The stock closed at $1.10 yesterday. The investors are speaking loud and clear about your leadership & vision. Are you so knuckle-headed that you do not get this message? How long should we keep faith in your constant effort to tell us how well we are doing, all that exciting stuff that is happening, the nice things to look forward to and all that other bull you have been giving us. No matter what you say, you can't fool the shareholders for too long, it just catches up with you, and before too long your employees will catch up to your sham. And where is the board of directors in all this sham of yours, or are they so deeply indebted to you that they continue to give you a free pass. This is got to end quickly.

The stock price has been on a downwards trend for a long time now. Under you leadership you have done a disservice to Uroplasty shareholders. Here is what you have done to them.

Uroplasty stock price at CGNT equivalent was $3.23 on December 19, the day before you announced the merger, and a high of $6.72 early in 2014 under your leadership. Under your disgraceful leadership, yesterday the stock closed at $1.10, for a shocking 66% loss from December 19, the day before the merger announcement, and doubly shocking 84% loss from the 2014 high.

The original Vision Science shareholders have not much to thank you either, but who cares about them, screw them. That company was a dying dog to start with. For all I know they are probably glad they dumped the company to you.
 






anonymous said:
Heavens, Rob how long can you justify remaining our CEO.

The stock closed at $1.10 yesterday. The investors are speaking loud and clear about your leadership & vision. Are you so knuckle-headed that you do not get this message? How long should we keep faith in your constant effort to tell us how well we are doing, all that exciting stuff that is happening, the nice things to look forward to and all that other bull you have been giving us. No matter what you say, you can't fool the shareholders for too long, it just catches up with you, and before too long your employees will catch up to your sham. And where is the board of directors in all this sham of yours, or are they so deeply indebted to you that they continue to give you a free pass. This is got to end quickly.

The stock price has been on a downwards trend for a long time now. Under you leadership you have done a disservice to Uroplasty shareholders. Here is what you have done to them.

Uroplasty stock price at CGNT equivalent was $3.23 on December 19, the day before you announced the merger, and a high of $6.72 early in 2014 under your leadership. Under your disgraceful leadership, yesterday the stock closed at $1.10, for a shocking 66% loss from December 19, the day before the merger announcement, and doubly shocking 84% loss from the 2014 high.

The original Vision Science shareholders have not much to thank you either, but who cares about them, screw them. That company was a dying dog to start with. For all I know they are probably glad they dumped the company to you.
Click to expand...
 






And now a $7MM line of credit??? A line of credit screams to everyone, AVOID AVOID AVOID!!! It essentially says we are not generating enough revenue to meet our operating expenses much less our revenue objectives. Very unfortunate indeed!
 






anonymous said:
Heavens, Rob how long can you justify remaining our CEO.

The stock closed at $1.10 yesterday. The investors are speaking loud and clear about your leadership & vision. Are you so knuckle-headed that you do not get this message? How long should we keep faith in your constant effort to tell us how well we are doing, all that exciting stuff that is happening, the nice things to look forward to and all that other bull you have been giving us. No matter what you say, you can't fool the shareholders for too long, it just catches up with you, and before too long your employees will catch up to your sham. And where is the board of directors in all this sham of yours, or are they so deeply indebted to you that they continue to give you a free pass. This is got to end quickly.

The stock price has been on a downwards trend for a long time now. Under you leadership you have done a disservice to Uroplasty shareholders. Here is what you have done to them.

Uroplasty stock price at CGNT equivalent was $3.23 on December 19, the day before you announced the merger, and a high of $6.72 early in 2014 under your leadership. Under your disgraceful leadership, yesterday the stock closed at $1.10, for a shocking 66% loss from December 19, the day before the merger announcement, and doubly shocking 84% loss from the 2014 high.

The original Vision Science shareholders have not much to thank you either, but who cares about them, screw them. That company was a dying dog to start with. For all I know they are probably glad they dumped the company to you.
Click to expand...
 






anonymous said:
Heavens, Rob how long can you justify remaining our CEO.

The stock closed at $1.10 yesterday. The investors are speaking loud and clear about your leadership & vision. Are you so knuckle-headed that you do not get this message? How long should we keep faith in your constant effort to tell us how well we are doing, all that exciting stuff that is happening, the nice things to look forward to and all that other bull you have been giving us. No matter what you say, you can't fool the shareholders for too long, it just catches up with you, and before too long your employees will catch up to your sham. And where is the board of directors in all this sham of yours, or are they so deeply indebted to you that they continue to give you a free pass. This is got to end quickly.

The stock price has been on a downwards trend for a long time now. Under you leadership you have done a disservice to Uroplasty shareholders. Here is what you have done to them.

Uroplasty stock price at CGNT equivalent was $3.23 on December 19, the day before you announced the merger, and a high of $6.72 early in 2014 under your leadership. Under your disgraceful leadership, yesterday the stock closed at $1.10, for a shocking 66% loss from December 19, the day before the merger announcement, and doubly shocking 84% loss from the 2014 high.

The original Vision Science shareholders have not much to thank you either, but who cares about them, screw them. That company was a dying dog to start with. For all I know they are probably glad they dumped the company to you.
Click to expand...

I do not think you should paint a broad brush on the board of directors.

Three board members are from the premerger vision science side of the business. They probably aren’t happy about Robs compensation package, leadership, vision or his performance, and probably are not indebted to Rob.

The rest of the board members are his lackeys. Rob brought some new members to the board, now indebted to him, or retained only the ones from the premerger Uroplasty board who were willing to tow Robs line. But since this group of lackeys forms a majority, they carry the day.

So don’t look to this lackey stashed board to make a change in leadership.
 


















anonymous said:
In case you missed it, check out this "Letter to Robert Kill" posted on yahoo finance message board.

http://finance.yahoo.com/mbview/threadview/?&bn=c5cfb991-0dd2-4b06-8747-c200f3ac63f2&tid=1445548864717-ba737517-aa1f-4e2e-abe7-dc4e88ba2369&tls=la,d,0,3

Will anything come out of this?
Click to expand...

Are you kidding me? This company is run by the biggest bunch of losers ever to be assembled. It will go down as a Harvard Business Review all time biggest failure and students will be studying Rob Kill as one of the all time worst CEO's in history.
 






Yea, you're right about your assessment of the leadership, which I think points a finger at Rob Kill. That guy is lacking in leadership skills. He only wants yes men around him and his idea of accountability is "my way or the highway." That is not leadership, that is commanding by fear, not conducive to team building.


Just look at his direct reports who have quit, who threatened to quit but were cajoled to remain and many who are planning to quit, primarily because they can't put up with his abrasive style.
 


















This guy is cutthroat, only in it for himself. The yes men he hires are overpaid, while the people who actually do the work are paid in pennies. With so many executive employees, no wonder the company is cash negative.
 






So is the merger with Vision producing the results one would expect given a sales force about 5 times bigger for the combined Companies. I do not think so. Just look at the trend line of Endosheath Urology product sales.

quarter immediately preceding the merger with Vision’s small sales force:
March 2015 Quarter $3.4 million

Post-merger with 5 x bigger sales force:
June 2015 Quarter $2.7 million
September 2015 Quarter $2.9 million.
So we have a 5 x bigger sales force and still cannot match the revenue produced by that much smaller sales force.

Now that the typical 6-month sales cycle for endosheath products is complete, the sales trend does not suggest good acceptance in the market place. This is a niche product. Let us face it, the market size for it is not very big.

Numbers speak louder than words. We can blindly pat ourselves in the back, or start asking some tough questions. You decide!!!
 






You missed telling us about how another important product in their line is doing, their US Urgent PC.

March 2015 Quarter: $4.8 million
June 2015 Quarter: $4.9 million
September 2015 Quarter: $5.1 million

This product too is not showing sequential growth in what RK & DH are telling us on how large and underpenetrated this market is, yet we are producing about flat line sales. Forty plus reps and this is all we can do?
 






as both a urologist and a long term gravely disappointed shareholder I share the overwhelming negative sentiment represented on this board. The only people who should be more embarrassed regarding the sales performance, and the stock performance as a surrogate of that than the CEO is the board of directors who propagate this. Fundamentally in the market place the opportunity for PTNS has never been greater yet mgmt can not monetize this vast opportunity. I would value hearing from those inside the company as to what is limiting to them and for them in their effort to drive sales.

Thank you
 






Hey Doc-maybe if you and 95% of your peers did not require a free lunch for your entire staff costing $200 just to have a 1 minute long conversation with you the financials may be a bit better. Just a thought.
 






Peter, your point is well taken. Being in an academic center we, my staff and I and colleagues, have not been able to participate in pharma/device rep lunches/dinners/events for the past few years. There are exceptions for "educational events" for the residents and fellows but I know less about that. What is the primary pushback you are getting from target physicians who are treating large numbers of puts with incontinence but not adopting PTNS?
 






anonymous said:
Peter, your point is well taken. Being in an academic center we, my staff and I and colleagues, have not been able to participate in pharma/device rep lunches/dinners/events for the past few years. There are exceptions for "educational events" for the residents and fellows but I know less about that. What is the primary pushback you are getting from target physicians who are treating large numbers of puts with incontinence but not adopting PTNS?
Click to expand...

Pushback is in many areas: Too many hassles to schedule patients, space constraints, and most of all not enough profit to make it their worthwhile. $$ drive their behavior, let us not be Pollyannaish.
 






Top Bottom
Back
Quote